Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Blood Specimen Collection 8Surveys and Questionnaires 7Fluorodeoxyglucose F18 4larotrectinib 3Magnetic Resonance Imaging 3Data Collection 3envafolimab 2Watchful Waiting 2Specimen Handling 2Quality of Life 2Psychiatric Rehabilitation 2Microarray Analysis 2Immunoenzyme Techniques 2Histocompatibility Testing 2Genetic Testing 2Gene Expression Profiling 2Fluorouracil 2Drug Therapy 2Blood Component Removal 2trifluridine tipiracil drug combination 1tegafur-gimeracil-oteracil 1etoposide phosphate 1disitamab vedotin 1alovudine 1Wechsler Scales 1Vascular Endothelial Growth Factor A 1Tumor Burden 1Tomography, Optical Coherence 1Tomography, Emission-Computed 1Tissue Banks 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Bleeding Time × Other solid neoplasm × Clear all
NCT00898794 2013-08-07

Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

National Cancer Institute (NCI)

Unknown
20 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡